SCHEMBL17762302

SCHEMBL17762302

CC(C)(C)OC(=O)C[C@@H](CCO)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2D6 P10635 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
FOLH1 Q04609 2/20 0.35
TDP1 Q9NUW8 2/20 0.34
CHRM1 P11229 1/20 0.34
AKR1A1 P14550 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18268296 1.00 MEN1 (0.45) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL4839844 0.86 MEN1 (0.47) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL6448846 0.85 HDAC1 (0.54) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL7051239 0.85 HDAC1 (0.54) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL16798232 0.85 HDAC1 (0.54) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL12047679 0.85 MEN1 (0.43) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL1915653 0.84 CA2 (0.55) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL1915651 0.84 CA2 (0.55) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL15629454 0.82 MEN1 (0.46) MEN1GAAKMT2ACYP2D6HDAC1
SCHEMBL16403067 0.82 MEN1 (0.42) MEN1GAAKMT2ACYP2D6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2016-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF CYP3A7, CYP2C19, CYP3A5 MEN1 1076/4885GAA 1153/4885KMT2A 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.